Valuation: TAKE LIMITED

Market Cap 1.64B 17.18M 15.39M 14.2M 12.85M 24.02M 24.41M 169M 67.57M 856M 64.48M 63.11M 2.71B P/E 2025
2.61x
P/E 2026 53.5x
Enterprise Value 1.45B 15.24M 13.65M 12.6M 11.4M 21.32M 21.66M 150M 59.96M 760M 57.21M 55.99M 2.41B EV / Sales 2025
-
EV / Sales 2026 10.5x
Free-Float
37.81%
Yield 2025 *
-
Yield 2026 -
1 day-1.81%
1 week-0.64%
Current month-18.41%
1 month-18.41%
3 months-47.20%
6 months-74.56%
Current year-72.81%
1 week 9.88
Extreme 9.88
11.53
1 month 9.88
Extreme 9.88
13.35
Current year 9.88
Extreme 9.88
50.14
1 year 9.88
Extreme 9.88
50.14
3 years 6.51
Extreme 6.51
50.14
5 years 6.51
Extreme 6.51
51.75
10 years 6.51
Extreme 6.51
308.25
Manager TitleAgeSince
Compliance Officer - 28/01/2026
Chief Tech/Sci/R&D Officer 56 -
Director TitleAgeSince
Director/Board Member - 24/05/2025
Director/Board Member 44 24/05/2025
Director/Board Member 47 24/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.63%-0.64%-51.43%-44.16% 16.37M
+0.34%+1.12%+34.75%+61.06% 64.14B
+0.98%+2.68%+12.25%+82.98% 55.53B
+1.75%+2.01%+13.30%+103.69% 53.03B
-1.43%-1.17%+26.27%+52.86% 45.99B
-0.48%-2.80%+18.01%+117.99% 42.45B
+0.82%+1.37%+227.94%+922.41% 40.45B
-2.07%+42.73%+103.77%+88.74% 34.47B
-0.26%-2.57%+12.55%+45.18% 32.25B
+0.09%-1.70%+23.07%-10.85% 24.23B
Average -0.23%+3.13%+42.05%+141.99% 39.26B
Weighted average by Cap. +0.09%+3.59%+49.29%+160.55%

Financials

2025 2026
Net sales - 542M 5.69M 5.1M 4.7M 4.25M 7.96M 8.09M 56.1M 22.38M 284M 21.35M 20.9M 898M
Net income 375M 3.93M 3.52M 3.25M 2.94M 5.5M 5.59M 38.79M 15.47M 196M 14.77M 14.45M 621M 108M 1.14M 1.02M 941K 852K 1.59M 1.62M 11.23M 4.48M 56.78M 4.28M 4.18M 180M
Net Debt -33.71M -354K -317K -293K -265K -495K -503K -3.49M -1.39M -17.64M -1.33M -1.3M -55.88M -184M -1.94M -1.73M -1.6M -1.45M -2.71M -2.75M -19.09M -7.62M -96.51M -7.27M -7.11M -306M
Projected Income Statement - Annual - TAKE LIMITED
Logo TAKE LIMITED
Take Limited, formerly Take Solutions Limited, is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like the Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.
Employees
5
Date Price Change Volume
30/10/26 ₹10.99 -0.63% 218,760
29/10/26 ₹11.06 +4.93% 294,380
28/10/26 ₹10.54 +3.94% 373,330
27/10/26 ₹10.14 -2.41% 749,798
26/10/26 ₹10.39 -4.94% 448,628
  1. Stock Market
  2. Stocks
  3. TAKE Stock